DE60326327D1 - Verfahren und zusammensetzungen zur identifikation und charakterisierung von hepatitis c - Google Patents

Verfahren und zusammensetzungen zur identifikation und charakterisierung von hepatitis c

Info

Publication number
DE60326327D1
DE60326327D1 DE60326327T DE60326327T DE60326327D1 DE 60326327 D1 DE60326327 D1 DE 60326327D1 DE 60326327 T DE60326327 T DE 60326327T DE 60326327 T DE60326327 T DE 60326327T DE 60326327 D1 DE60326327 D1 DE 60326327D1
Authority
DE
Germany
Prior art keywords
characterization
compositions
identification
hcv
hepatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60326327T
Other languages
English (en)
Inventor
Carol Holland-Staley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lab 21 Ltd
Original Assignee
Lab 21 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lab 21 Ltd filed Critical Lab 21 Ltd
Application granted granted Critical
Publication of DE60326327D1 publication Critical patent/DE60326327D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60326327T 2002-03-11 2003-03-11 Verfahren und zusammensetzungen zur identifikation und charakterisierung von hepatitis c Expired - Lifetime DE60326327D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36360302P 2002-03-11 2002-03-11
PCT/US2003/007585 WO2003077729A2 (en) 2002-03-11 2003-03-11 Methods and compositions for identifying and characterizing hepatitis c

Publications (1)

Publication Number Publication Date
DE60326327D1 true DE60326327D1 (de) 2009-04-09

Family

ID=28041784

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60332781T Expired - Lifetime DE60332781D1 (de) 2002-03-11 2003-03-11 Verfahren und Zusammensetzungen zur Identifizierung und Charakterisierung von Hepatitis C
DE60326327T Expired - Lifetime DE60326327D1 (de) 2002-03-11 2003-03-11 Verfahren und zusammensetzungen zur identifikation und charakterisierung von hepatitis c

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE60332781T Expired - Lifetime DE60332781D1 (de) 2002-03-11 2003-03-11 Verfahren und Zusammensetzungen zur Identifizierung und Charakterisierung von Hepatitis C

Country Status (9)

Country Link
US (3) US20070172926A1 (de)
EP (3) EP2014671B1 (de)
AT (3) ATE423785T1 (de)
AU (2) AU2003218111B8 (de)
DE (2) DE60332781D1 (de)
DK (3) DK1490383T3 (de)
ES (3) ES2346717T3 (de)
PT (3) PT2014671E (de)
WO (1) WO2003077729A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60332781D1 (de) 2002-03-11 2010-07-08 Lab 21 Ltd Verfahren und Zusammensetzungen zur Identifizierung und Charakterisierung von Hepatitis C
AU2006235438A1 (en) * 2005-04-11 2006-10-19 Achillion Pharmaceuticals, Inc. Pharmaceutical compositions for and methods of inhibiting HCV replication
JP2009512426A (ja) * 2005-10-14 2009-03-26 イヴァン・ペテャエフ 偏性細胞内病原体の治療および診断
CN100365124C (zh) * 2005-10-27 2008-01-30 云南大学 一段丙型肝炎病毒特异性cDNA序列的应用
US20080015834A1 (en) * 2006-07-13 2008-01-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for molecular inhibition
US20080014572A1 (en) * 2006-07-13 2008-01-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for molecular inhibition
US20090082344A1 (en) * 2006-07-13 2009-03-26 Searete Llc Methods and systems for treating disease
EP2463390A1 (de) 2006-10-20 2012-06-13 Innogenetics N.V. Methodik zur Analyse von Sequenzvariationen innerhalb des HCV-NS5B-Genombereichs
EP2121991A2 (de) 2006-10-20 2009-11-25 Innogenetics N.V. Methodik zur analyse von sequenzvariationen innerhalb des hcv-ns3/4a-genombereichs
BRPI0818488A2 (pt) * 2007-10-30 2015-04-14 Intermune Inc Genotipagem e fenotipagem de hcv
ES2361598T3 (es) * 2007-10-31 2011-06-20 Debiopharm S.A. Análisis del genoma casi completo de la resistencia a fármacos del hcv.
EP2576823A1 (de) 2010-06-04 2013-04-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Konstitutiv aktive prolactin-rezeptorvarianten als prognostische marker und therapeutische ziele zur vorbeugung des fortschritts von hormonabhängigen karzinomen in richtung hormonunabhängigkeit
WO2012177739A2 (en) * 2011-06-20 2012-12-27 Siemens Healthcare Diagnostics Inc. Reagents and methods for detecting hcv
AU2013205064B2 (en) * 2012-06-04 2015-07-30 Gen-Probe Incorporated Compositions and Methods for Amplifying and Characterizing HCV Nucleic Acid

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
ES2012739T5 (es) 1987-11-18 2001-12-01 Chiron Corp Diagnosticos para nanbv.
US5350671A (en) 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
EP0435229A1 (de) * 1989-12-27 1991-07-03 Sanwa Kagaku Kenkyusho Co., Ltd. DNS-Gen von einem Non-A Non-B Hepatitis-Virus, seine Klonierung und Verwendung
US5747339A (en) * 1990-06-25 1998-05-05 Research Foundation For Microbial Diseases Of Osaka Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
WO1993000365A2 (en) * 1991-06-24 1993-01-07 Chiron Corporation Hepatitis c virus (hcv) polypeptides
US20030125270A1 (en) * 2000-12-18 2003-07-03 Lawrence Blatt Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis C virus infection
CA2662090A1 (en) * 1993-04-27 1994-11-10 N.V. Innogenetics S.A. New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
DE69434116T2 (de) * 1993-05-05 2005-10-27 Common Services Agency Hepatitis-c virus typ 4,5 und 6
US5571673A (en) * 1994-11-23 1996-11-05 Hoffmann-La Roche Inc. Methods for in-solution quenching of fluorescently labeled oligonucleotide probes
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US6242187B1 (en) * 1996-01-29 2001-06-05 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US7338759B1 (en) * 1997-03-04 2008-03-04 Washington University HCV variants
US6153421A (en) * 1997-07-18 2000-11-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Cloned genomes of infectious hepatitis C viruses and uses thereof
CA2298102A1 (en) * 1997-07-30 1999-02-11 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US6280940B1 (en) * 1998-08-05 2001-08-28 Agouron Pharmaceuticals, Inc. Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease
ATE404698T1 (de) * 2000-04-18 2008-08-15 Virco Bvba Methode zur bestimmung der resistenz gegen medikamente
CA2409873C (en) * 2000-05-23 2013-01-08 Washington University Hcv variants
EP1373576A4 (de) * 2000-07-24 2005-06-15 Inst Of Molecul & Cell Biology Nukleinsäuren und verfahren zum nachweis viraler infektionen, aufspüren von anti-viralen verbindungen und bestimmiung der medikamentenresistenz von virusisolaten
US6680059B2 (en) * 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
DE60332781D1 (de) 2002-03-11 2010-07-08 Lab 21 Ltd Verfahren und Zusammensetzungen zur Identifizierung und Charakterisierung von Hepatitis C

Also Published As

Publication number Publication date
AU2003218111B2 (en) 2008-11-06
EP2014671A1 (de) 2009-01-14
PT1947104E (pt) 2012-08-09
US20070172926A1 (en) 2007-07-26
EP1490383B1 (de) 2009-02-25
US20090047663A1 (en) 2009-02-19
DK1490383T3 (da) 2009-06-08
WO2003077729A2 (en) 2003-09-25
ES2386742T3 (es) 2012-08-28
PT1490383E (pt) 2009-05-25
AU2003218111A1 (en) 2003-09-29
AU2008249300B2 (en) 2012-08-16
ATE556084T1 (de) 2012-05-15
AU2008249300A1 (en) 2008-12-18
EP1947104B1 (de) 2012-05-02
US8173795B2 (en) 2012-05-08
DK2014671T3 (da) 2010-09-20
ATE423785T1 (de) 2009-03-15
EP1947104A3 (de) 2009-04-08
PT2014671E (pt) 2010-06-16
EP1490383A2 (de) 2004-12-29
US20120322051A1 (en) 2012-12-20
EP1947104A2 (de) 2008-07-23
EP2014671B1 (de) 2010-05-26
ES2346717T3 (es) 2010-10-19
DK1947104T3 (da) 2012-08-06
WO2003077729A3 (en) 2004-06-03
EP1490383A4 (de) 2005-12-21
WO2003077729A9 (en) 2004-04-22
DE60332781D1 (de) 2010-07-08
ES2321498T3 (es) 2009-06-08
ATE469162T1 (de) 2010-06-15
AU2003218111B8 (en) 2008-11-20

Similar Documents

Publication Publication Date Title
DE60326327D1 (de) Verfahren und zusammensetzungen zur identifikation und charakterisierung von hepatitis c
ATE432365T1 (de) Verfahren, kits und reagenzien zur nukleinsäuresequenzierung
DE60039037D1 (de) Methode zur direkten sequenzierung von nukleinsäuren
ATE428003T1 (de) Oligonukleotidprimer zur effizienten detektion von hepatitis c virus (hcv) sowie verwendungsverfahren
DE69433487D1 (de) Methoden und zusammensetzungen zur effizienten nukleinsaeuresequenzierung
DE69837913D1 (de) Verfahren zur vervielfältigung von nukleinsäure
HK1074458A1 (en) Thermostable taq polymerase fragment
ATE542917T1 (de) Zusammensetzungen, verfahren und kits zur bestimmung des vorhandenseins von trichomonas vaginalis in einer testprobe
ATE485391T1 (de) Zusammensetzungen, methoden und testssysteme zur bestimmung der präsenz von cryptosporidium organismen in einer testprobe
ATE445023T1 (de) Auf nukleinsäurenamplifizierung basierendes verfahren zur bestimmung von methylierungsprofil und reagenzien dafür
ATE516365T1 (de) Nukleinsäureamplifikationsprimer zum nachweis von cytokeratinen und untersuchungsverfahren mit verwendung der primer
DE60324819D1 (de) Verfahren zur amplifikation von nukleinsäure, kit zur amplifikation von nukleinsäure, verfahren zum nachweis von einzelnukleotid-polymorphismus und reagentienkit zum nachweis von einzelnukleotid-polymorphismus
ATE312204T1 (de) Methoden und zusammensetzungen zur detektion von spezies des mycobacterium avium-komplexes
DE60015210D1 (de) Oligonukleotid Primer zur effizienten reversen Transkription von Hepatitis C Virus (HCV) RNS und Verfahren zu deren Verwendung
DE59912683D1 (de) Verfahren und Zusammensetzungen zur Isolierung und Reinigung von Nukleinsäuren
ATE486932T1 (de) Thermostabile dna polymerase von archae ampullavirus abv und dessen verwendungen
ATE440153T1 (de) Verfahren und kit zur abschätzung der nebenwirkung durch eine paclitaxel-therapie
ATE328117T1 (de) Verfahren und sonden zur genetischen diagnose von heriditärer hämochromatose
ATE414175T1 (de) Detektion von rpob sequenzen von mycobacterium tuberculosis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition